Meeting
2022 ASCO Genitourinary Cancers Symposium
Long-term outcomes of a pilot study on highly hypofractionated intensity-modulated radiation therapy over three weeks for localized prostate cancer.
Authors
Kiyonao Nakamura
Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan
Kiyonao Nakamura , Itaru Ikeda , Haruo Inokuchi , Rihito Aizawa , Shusuke Akamatsu , Takashi Kobayashi , Takashi Mizowaki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 259)
DOI
10.1200/JCO.2022.40.6_suppl.259
Abstract #
259
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Comparative effectiveness of intensity-modulated radiation therapy versus three-dimensional conformal radiation for localized prostate cancer.
First Author: Talha Shaikh
Poster
2014 Genitourinary Cancers Symposium
Long-term clinical and toxicity outcomes of hypofractionated intensity-modulated radiation therapy for clinically localized prostate cancer.
First Author: Rupesh Kotecha
Poster
2022 ASCO Genitourinary Cancers Symposium
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.
First Author: David James Carpenter
Poster
2020 Genitourinary Cancers Symposium
Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage.
First Author: Anthony Ricco